Pyrexia, commonly known as fever, is a prevalent clinical symptom that requires careful evaluation and management.
Fever is the body's response to inflammation or infection, resulting from an increase in the set-point of body temperature in the hypothalamus.
Assessment involves history taking, physical examination, and necessary investigations. Fever of unknown origin (FUO) poses a diagnostic challenge.
Treatment should target the underlying cause. Antipyretics can be used for symptomatic relief but do not treat the root cause.
Effective management of pyrexia involves a thorough understanding of its etiology, careful assessment, and targeted treatment strategies.
1.
Guidelines for patient training and radiation protection for patients treated with radioactive iodine for thyroid cancer
2.
Acupuncture may alleviate nocturia in men treated for prostate cancer
3.
Inadvertent lung cancer screening results are discussed in a new study.
4.
Patients face high out-of-pocket costs after incident cancer diagnosis
5.
Rucaparib Delays Next Lines of Therapy in Ovarian Cancer
1.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
2.
The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease
3.
Understanding Macrocytosis: Causes, Symptoms, and Treatment Options
4.
Unveiling the Mystery Behind Lymphovascular Invasion
5.
Cardio-Oncology: Managing Heart Failure in Survivors of Cancer
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
3.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation